Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.
Monge, Susana Humphreys, James Nicolay, Nathalie Braeye, Toon Van Evercooren, Izaak Holm Hansen, Christian Emborg, Hanne-Dorthe Sacco, Chiara Mateo-Urdiales, Alberto Castilla, Jesús
Monge, Susana
Humphreys, James
Nicolay, Nathalie
Braeye, Toon
Van Evercooren, Izaak
Holm Hansen, Christian
Emborg, Hanne-Dorthe
Sacco, Chiara
Mateo-Urdiales, Alberto
Castilla, Jesús
Citations
Altmetric:
Series / Report no.
Open Access
Type
Article
Language
en
Date of publication
2024-04-30
Year of publication
Research Projects
Organizational Units
Journal Issue
Title
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.
Translated Title
Published in
Influenza Other Respir Viruses 2024;18(4):e13292